InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by MARAGANORE JOHN, Chief Executive Officer. Insider active across 4 companies, notably Alnylam Pharmaceuticals, INC.. Cumulatively, 13 reports have been logged. The latest transaction was filed on 20 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
01,585 shares0
Common stock
SEC:0001439222-22-000049:0·
014,167 shares0
Common Stock
SEC:0001735276-21-000095·
014,167 shares0
Common Stock
SEC:0001735276-21-000095:0·
€88,4791,036 shares@ €85.40450.0002% mcap17.5% of flow
Common Stock
SEC:0001735276-21-000091·
€88,4791,036 shares@ €85.40450.0002% mcap7.3% of flow
Common Stock
SEC:0001735276-21-000091:0·
€210,67833,978 shares@ €6.20040.0005% mcap41.7% of flow
Common Stock
SEC:0001735276-21-000089·
€210,67833,978 shares@ €6.20040.0005% mcap17.4% of flow
Common Stock
SEC:0001735276-21-000089:0·
€205,56033,979 shares@ €6.04960.0005% mcap17.0% of flow
Common Stock
SEC:0001735276-21-000083·
€205,56033,979 shares@ €6.04960.0005% mcap17.0% of flow
Common Stock
SEC:0001735276-21-000083:0·
03,415 shares0
Common stock
SEC:0001439222-21-000054·
03,415 shares0
Common stock
SEC:0001439222-21-000054:0·
€199,75633,979 shares@ €5.8788100.0% of flow
Common Stock
SEC:0001735276-21-000044·
€199,75633,979 shares@ €5.87880.0005% mcap16.5% of flow
Common Stock
SEC:0001735276-21-000044:0·
13 of 13 declarations
About MARAGANORE JOHN
John Maraganore is the CEO and Director at ALNYLAM PHARMACEUTICALS, INC. and AGIOS PHARMACEUTICALS, INC. In these roles, he is responsible for the strategic and operational direction of the companies. His experience in the biopharmaceutical sector is crucial for the development and growth of Alnylam and Agios.
